Your fasting glucose is 92 mg/dL. Your doctor says it is normal. You move on with your day.
But what if the real story is hiding behind a number your doctor never ordered?
Fasting insulin is the metabolic marker that detects trouble 5–10 years before fasting glucose does. It is the early warning system for insulin resistance, type 2 diabetes, cardiovascular disease, and metabolic syndrome. And most physicians do not routinely test it.
Why fasting insulin matters more than you think
Here is the key insight: your body will fight to keep blood glucose in a narrow range. It does this by producing more insulin. So in the early stages of insulin resistance, your glucose looks fine — because your pancreas is compensating by pumping out extra insulin.
This is called compensatory hyperinsulinemia. Your glucose is 90 mg/dL. Everything looks great. But your insulin is 20 µIU/mL — your pancreas is working overtime to achieve that result.
Eventually, the pancreas cannot keep up. Glucose starts rising. First to 100, then 110, then 126 mg/dL (the diabetes threshold). But by that point, you have been insulin resistant for years — possibly a decade.
Fasting insulin catches the problem at the beginning, not the end.
Fasting insulin levels chart
Here is how to interpret your fasting insulin level:
| Fasting insulin (µIU/mL) | Interpretation |
|---|---|
| Below 3 | Very insulin sensitive — typical of lean, active individuals |
| 3–5 | Optimal — the target range for metabolic health and longevity |
| 5–8 | Normal — within healthy range for most adults |
| 8–12 | Borderline — early insulin resistance may be developing |
| 12–20 | Elevated — significant insulin resistance likely present |
| Above 20 | High — strong indicator of metabolic syndrome or pre-diabetes |
| Above 25 | Very high — almost always associated with metabolic dysfunction |
Important context
Standard lab reference ranges will call anything from about 2.6 to 24.9 µIU/mL "normal." This is misleading. Lab ranges reflect the tested population, and in the United States, over 88% of adults have at least one marker of metabolic dysfunction (according to a 2019 UNC Chapel Hill study). The "normal" range is skewed by a metabolically unhealthy population.
An optimal fasting insulin is not just below the upper lab limit — it is well below it.
Fasting insulin by age and sex
Fasting insulin tends to increase with age, driven by declining muscle mass, increasing visceral fat, reduced physical activity, and hormonal changes. But this increase is not inevitable — it is modifiable.
| Age group | Typical range (µIU/mL) | Optimal target |
|---|---|---|
| 18–30 | 3–10 | Below 6 |
| 30–40 | 4–12 | Below 7 |
| 40–50 | 5–15 | Below 8 |
| 50–60 | 5–18 | Below 8 |
| 60+ | 5–20 | Below 10 |
Women may see fluctuations across the menstrual cycle and during perimenopause/menopause due to estrogen's effect on insulin sensitivity. Polycystic ovary syndrome (PCOS) is one of the most common causes of elevated fasting insulin in premenopausal women.
HOMA-IR: combining insulin and glucose
Fasting insulin is most powerful when paired with fasting glucose to calculate HOMA-IR (Homeostatic Model Assessment of Insulin Resistance):
HOMA-IR = (Fasting Glucose mg/dL × Fasting Insulin µIU/mL) ÷ 405
| HOMA-IR | Interpretation |
|---|---|
| Below 1.0 | Excellent insulin sensitivity |
| 1.0–1.5 | Optimal |
| 1.5–2.0 | Normal but worth monitoring |
| 2.0–2.9 | Early insulin resistance |
| 3.0+ | Significant insulin resistance |
A HOMA-IR above 2.5 is widely used in research as the threshold for insulin resistance. Many longevity physicians prefer to see it below 1.5.
Why your doctor probably does not test it
Fasting insulin is not included in the standard basic metabolic panel (BMP) or comprehensive metabolic panel (CMP). The current screening guidelines from the ADA (American Diabetes Association) focus on fasting glucose and HbA1c — both of which detect diabetes at a later stage.
The reasons fasting insulin is not standard:
- Guidelines lag behind research — clinical guidelines take years to update, and fasting insulin's utility is still debated in traditional endocrinology
- Cost sensitivity — adding tests increases healthcare costs, and insurers push for the minimum
- Treatment threshold uncertainty — there is no universally agreed treatment target for fasting insulin (unlike HbA1c > 6.5% = diabetes)
- Variability — insulin levels can fluctuate based on recent meals, stress, sleep, and time of day
None of these are reasons to ignore it. They are reasons the system has been slow to adopt it.
The metabolic progression timeline
Understanding the typical progression from healthy to diabetic makes the case for early testing:
- Years 0–5: Insulin rises. Glucose stays normal. Standard tests show nothing wrong.
- Years 5–10: Fasting glucose creeps to 100–110 mg/dL. HbA1c reaches 5.7%. Now labeled "pre-diabetic."
- Years 10–15: Pancreatic beta cells begin to fail. Glucose crosses 126 mg/dL. Diabetes is diagnosed.
Fasting insulin detects the problem at stage 1. Fasting glucose detects it at stage 2. HbA1c confirms it at stage 2–3.
By the time you are diagnosed with type 2 diabetes, you have likely lost 50–80% of your beta cell function. This is not a sudden event. It is a slow decline that fasting insulin could have flagged a decade earlier.
How to lower fasting insulin
Exercise — the most powerful tool
Exercise is the single most effective way to improve insulin sensitivity:
- Resistance training builds muscle mass, and muscle is the primary tissue for glucose disposal. More muscle means more capacity to absorb glucose without needing high insulin.
- Aerobic exercise (especially zone 2 training at 60–70% max heart rate) improves mitochondrial function and fat oxidation.
- High-intensity interval training (HIIT) acutely improves GLUT4 transporter activity on muscle cells.
Even a single session of exercise improves insulin sensitivity for 24–48 hours. Consistency compounds the effect.
Dietary strategies
- Reduce refined carbohydrates and sugar — these cause the largest insulin spikes
- Prioritize protein and healthy fats — both blunt the insulin response compared to carbohydrate-dominant meals
- Increase fiber intake — soluble fiber slows glucose absorption, reducing insulin demand
- Consider time-restricted eating — limiting eating to an 8–10 hour window gives insulin levels time to fall and stay low
- Limit fructose — particularly from sugary beverages, which drive hepatic insulin resistance
Sleep and stress
- Poor sleep (under 6 hours or fragmented) increases insulin resistance within days. One study showed a single night of sleep restriction to 4 hours reduced insulin sensitivity by 25%.
- Chronic stress elevates cortisol, which directly antagonizes insulin action. Cortisol tells the liver to release glucose, requiring more insulin to compensate.
Body composition
Visceral fat (the fat around your organs) is uniquely inflammatory and insulin-resistance-promoting. Losing even 5–10% of body weight in people with excess visceral fat can dramatically lower fasting insulin.
When to test fasting insulin
Consider asking your doctor for a fasting insulin test if you have:
- A family history of type 2 diabetes
- A waist-to-hip ratio above 0.85 (women) or 0.90 (men)
- Elevated triglycerides or low HDL-C
- PCOS or irregular menstrual cycles
- Difficulty losing weight despite caloric restriction
- Fatigue after meals or frequent sugar cravings
- An HbA1c between 5.4–5.6% (high-normal)
Or simply if you want an earlier signal of metabolic health than fasting glucose alone.
In the US, you can order a fasting insulin test directly through services like Quest Diagnostics or LabCorp, often for under $30 without a physician order.
How Merios helps
Upload your blood test results to Merios and we extract fasting insulin, fasting glucose, and automatically calculate your HOMA-IR. Track these values over time — before and after lifestyle changes — and see them alongside your Apple Watch data (resting heart rate, HRV, activity) for a complete metabolic picture. Metabolic health is not a single number; it is a trend.
Track your fasting insulin with Merios →
This article is for informational purposes only and does not constitute medical advice. Discuss metabolic health screening with your physician.